Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01422837 · ClinicalTrials.gov registry record
ALK21-025: Vivitrol's Cost and Treatment Outcomes Registry
A clinical trial of Opioid Dependence, sponsored by Alkermes.
- Completed
- Registry status
- 403
- Enrollment target
- 20
- Study locations
NCT01422837: Completed study of Opioid Dependence, sponsored by Alkermes.
NCT01422837 is a study of Opioid Dependence that has completed, run by Alkermes. The registered enrollment target is 403 participants, above the 144-participant average among 29 other Opioid Dependence trials with a reported enrollment target (180% higher). The trial reports 20 study locations across 11 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01422837, a study of Opioid Dependence, has completed, sponsored by Alkermes.
- COMPLETED
- Registry status
- 403 participants
- Enrollment target
- 20
- Study locations
Study Summary
The objective of the VIVITROL Registry is to gather real world data on opioid dependence and to provide understanding of the health economics of opioid dependence.
Conditions Studied
Study Locations (20)
California
- Amy Solomon, MD - Ben Lomond
- Touchstone Medical Group - Clovis
- Kenneth C. Russ, MD - Palm Springs
- Tarzana Treatment Centers - Tarzana
New York
- Dent Neurologic Institute - Amherst
- Dr. Michael Sanders - Great Neck
- Fakhouri Medical - Hopewell Junction
- Parallax Center - New York
Florida
- Jacqueline Boutrouille, MD - Tamarac
- Alliance Clinical Research - Winter Park
Georgia
- Atlanta Institute of Medicine and Research - Atlanta
- PACT Atlanta - Decatur
Massachusetts
- Gosnold-Thorne Counseling Center - Centerville
- Dr. Li's Clinic - Milford
Arizona
- Assisted Recovery Centers of America - Phoenix
Arkansas
- Arkansas Psychiatric Clinc - Little Rock
Colorado
- The NeuroBehavioral Institute of Colorado, PC - Lone Tree
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 403 participants |
| Start Date | 2011-08 |
| Est. Completion | 2013-10 |
What the finished NCT01422837 record still lists
NCT01422837 is an observational study that tracks outcomes without assigning an intervention. The registered 403 participants enrollment target is mid-sized for trials with a published cap, above the 144-participant average among 29 other Opioid Dependence trials with a reported enrollment target (180% higher).
The record links to 1 condition, with Opioid Dependence appearing as the primary indexed condition, and to 0 interventions.
NCT01422837 names 20 study sites across 11 states, led by California, New York, Florida.
Frequently Asked Questions
What is clinical trial NCT01422837 about?
NCT01422837 is a clinical study titled "ALK21-025: Vivitrol's Cost and Treatment Outcomes Registry". The objective of the VIVITROL Registry is to gather real world data on opioid dependence and to provide understanding of the health economics of opioid dependence.
What is the current status of trial NCT01422837?
This trial is currently completed. The enrollment target is 403 participants. The study started on 2011-08. Estimated completion is 2013-10.
What conditions does trial NCT01422837 study?
This clinical trial studies the following conditions: Opioid Dependence.
Who is sponsoring clinical trial NCT01422837?
This trial is sponsored by Alkermes, which has 66 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01422837 being conducted?
This trial has 20 study locations across Arizona, Arkansas, California, Colorado, Connecticut. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Opioid Dependence
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT01422837's enrollment target sits among peer trials
403 3rd of 29 higher than 27 of 29 other Opioid Dependence trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Opioid Dependence trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Neuromodulation and Cognitive Training in Opioid Use Disorder
RECRUITING · NA
-
Intervening With Opioid-Dependent MothersMothers and Infants
RECRUITING · NA
-
fMRI and Opioid Abstinence
RECRUITING
-
Better Options for Chronic Cancer Pain
RECRUITING · Phase 4
-
Young Houston Emergency Opioid Engagement System
RECRUITING · Phase 4
-
Buprenorphine as a Post-operative Analgesic in Opioid-Naive Patients After Ankle Fracture Surgery
RECRUITING · Phase 4
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05647122 · 403 participants · Phase 1
First in Human Study of AZD9592 in Solid Tumors
- NCT05674799 · 403 participants · NA
NDPP-NextGen: A Clinical Trial to Reduce Intergenerational Obesity and Diabetes Risks
- NCT06244771 · 403 participants · Phase 1
A Study Evaluating FMC-376 in Participants With KRAS G12C Mutated Solid Tumors
- NCT05049057 · 404 participants · Phase 2
Treatment of Acute PTH With a CGRP Receptor mAb in Military Service Members and Civilians With mTBI
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia